Clinical Trial Update: A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing amisulpride to placebo for prevention of postoperative nausea and vomiting (PONV) in high-risk patients; status currently unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd. | Conditions: PONV | Phase 3 | Status: UNKNOWN